AIC | −2 (Log-Likelihood) | R^{2a} | AUC | OR | 95% CI | P Value | |
---|---|---|---|---|---|---|---|

Favorable clinical outcome | |||||||

Model of SPAN-100 only | 316.64 | 312.64 | 0.054 | 0.599 | 0.56–0.64 | ||

SPAN-100 | 0.2 | 0.1–0.4 | |||||

Model of SPAN-100, CBS | 307.42 | 301.42 | 0.088 | 0.676 | 0.61–0.74 | .004 | |

SPAN-100 | 0.2 | 0.1–0.3 | |||||

CBS | 1.2 | 1.1–1.3 | |||||

Model of SPAN-100, CBS, CBV | 294.09 | 286.09 | 0.135 | 0.742 | 0.68–0.80 | <.001 | |

SPAN-100 | 0.2 | 0.1–0.5 | |||||

CBS | 1.1 | 1.0–1.2 | |||||

CBV | 0.6 | 0.5–0.8 | |||||

Hemorrhagic transformation | |||||||

Model of SPAN-100 only | 342.06 | 338.06 | 0.019 | 0.55 | 0.49–0.60 | ||

SPAN-100 | 2.0 | 1.1–3.8 | |||||

Model of SPAN-100, CBS | 339.39 | 333.392 | 0.037 | 0.62 | 0.54.5–0.69 | .02 | |

SPAN-100 | 2.2 | 1.2–4.1 | |||||

CBS | 0.9 | 0.8–0.9 |

**Note:**—AIC indicates Akaike information criterion.↵a

*R*^{2}is the proportion of variability in a dataset that is accounted for by the statistical model.